Please provide your email address to receive an email when new articles are posted on . Relfydess has received a positive decision for treatment of frown lines and crow’s feet in the European Union.

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at ...